This medical device firm supplies hospitals worldwide with single-use products for critical care, surgery, and interventional procedures.

The recent Teleflex update centers on a refreshed fair value estimate, which has shifted from about US$124.14 to about US$129.25 as analysts tweak their models for revenue growth and the discount rate ...

Teleflex TFX posted solid fourth-quarter performance, ending the year on a stable note. On one hand, currency was a major headwind across all segments this fiscal year, and supply chain and staffing ...

The latest announcement is out from Teleflex ( (TFX) ).

Acquisition will further advance Teleflex’s Interventional portfolio with a differentiated global suite of coronary vascular and peripheral vascular intervention devices WAYNE, Pa., Feb. 27, 2025 ...

WAYNE, Pa., May 19, 2025 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced it has published its 2024 Global Impact Report. The ...

Ratings for Teleflex (NYSE:TFX) were provided by 6 analysts in the past three months, showcasing a mix of bullish and bearish perspectives. Summarizing their recent assessments, the table below ...

Teleflex’s TFX Interventional Urology portfolio is well positioned for sustained growth, led by UroLift’s expanding global footprint and strong clinical differentiation. Supported by favorable ...

Teleflex Incorporated (NYSE:TFX) reported better-than-expected earnings for the third quarter on Thursday. The company posted quarterly earnings of $3.67 per share which beat the analyst consensus ...

The what, where, when, why and how was known, but the who behind a new, roughly 150-employee medical device research facility being built on former VF Outlet Center property in Wyomissing was the big ...

Look here for a clue. There's no foolproof way to know the future for Teleflex (NYSE: TFX) or any other company. However, certain clues may help you see potential stumbles before they happen -- and ...